Salvage Robot-Assisted Radical Prostatectomy for Recurrent Localized Prostate Cancer after Radiation Therapy
According to the literature, approximately 50% of patients treated with first-line radiotherapy have biochemical recurrence at 10 years and it has been reported that up to 60% of patients will experience local recurrence (Agarwal PK, Sadetsky N, Konety BR
- PDF / 4,888,955 Bytes
- 273 Pages / 439.43 x 683.15 pts Page_size
- 72 Downloads / 234 Views
123
Salvage Therapy for Prostate Cancer
Sanchia S. Goonewardene Raj Persad • Karen Ventii David Albala • Declan Cahill Editors
Salvage Therapy for Prostate Cancer
Editors Sanchia S. Goonewardene Southend University Hospital NHS Foundation Trust Southend UK Karen Ventii Harvard University Boston MA USA
Raj Persad North Bristol NHS Foundation Trust Bristol UK David Albala Department of Urology Crouse Hospital Syracuse NY USA
Declan Cahill Royal Marsden Hospital London UK
ISBN 978-3-030-57180-1 ISBN 978-3-030-57181-8 (eBook) https://doi.org/10.1007/978-3-030-57181-8 © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021 This work is subject to copyright. All rights are solely and exclusively licensed by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Preface
Welcome to Salvage Therapy for Prostate Cancer. On behalf of my team and I, it has been a pleasure putting this together for you. This is an important topic for both patients and clinicians alike and was specifically written for clinicians like you. Years ago, when I was a fellow at Guy’s and St Thomas’ Hospitals, I came across this topic as a young registrar. Clearly, it is an area which often results in a difficult situation for both clinician and patient—the patient has failed their primary therapy for prostate cancer. What do you do next? It is often the time when treatment options may become narrower or you may be running out of curative treatment options. Now, having had experience of prostate cancer management, I realised this book needed to be written. We are lucky to have experts from around the world contributing to this book. There are many difficult topics we deal with, from which type of salvage therapy is best, t
Data Loading...
